Intelligence Profile
Safety Profile
The safety profile of pregnenolone is not comprehensively established in the available evidence. While several clinical trials have been conducted or are ongoing, detailed safety data from these studies is not provided in the current evidence base.
Known Side Effects
Evidence is thin. The available research does not provide specific information about common or serious side effects associated with pregnenolone supplementation. Clinical trials have been completed for conditions including marijuana dependence, chronic pain, alcohol use disorder, and mild traumatic brain injury, but their safety outcomes are not detailed in the current evidence.
Contraindications
No specific contraindications are identified in the available evidence. This represents a significant gap in the safety profile, as contraindications would typically be established through clinical studies and post-market surveillance.
Drug Interactions
Evidence is extremely limited. While pregnenolone is involved in steroidogenic pathways and could theoretically interact with medications affecting hormone metabolism, no specific drug interactions are documented in the provided evidence. One study mentions interactions with "Western antihypertensive drugs" in combination with other compounds, but does not provide specific interaction data for pregnenolone alone.
Special Populations
Pregnancy and Lactation: The evidence includes research on maternal exposure and neonatal steroid levels, suggesting pregnenolone crosses placental barriers and affects fetal development. However, specific safety guidance for pregnant or breastfeeding women is not provided.
Pediatric Populations: Research includes neonatal reference intervals for steroid hormones, but safety data for pregnenolone use in children is not established in the available evidence.
Hormone-Sensitive Conditions: Given pregnenolone's role as a precursor to various steroid hormones (as evidenced by studies on polycystic ovary syndrome and steroidogenic pathways), individuals with hormone-sensitive conditions may need special consideration, though specific guidance is not provided in the current evidence.
Evidence Limitations
The safety profile presented here is severely limited by the lack of comprehensive clinical safety data in the available evidence. Most studies focus on metabolic pathways, analytical methods, or are observational in nature rather than interventional safety studies. Healthcare providers should exercise caution and consult additional safety resources before recommending pregnenolone supplementation.
This information is for educational purposes only and should not replace professional medical advice. Consult with a healthcare provider before using pregnenolone, especially if you have existing medical conditions or are taking medications.